Dongfang Liu - 25 Nov 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Stephen Dang, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
25 Nov 2025
Net transactions value
-$82,800
Form type
4
Filing time
26 Nov 2025, 17:55:20 UTC
Previous filing
24 Nov 2025
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Liu Dongfang CHIEF MEDICAL OFFICER C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK /s/ Stephen Dang, Attorney-in-Fact 26 Nov 2025 0001937915

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Class A Common Stock Options Exercise $36,100 +10,000 +56% $3.61 28,000 25 Nov 2025 Direct
transaction NUVB Class A Common Stock Sale $75,000 -10,000 -36% $7.50 18,000 25 Nov 2025 Direct
transaction NUVB Class A Common Stock Options Exercise $36,100 +10,000 +56% $3.61 28,000 26 Nov 2025 Direct
transaction NUVB Class A Common Stock Sale $80,000 -10,000 -36% $8.00 18,000 26 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Options Exercise $0 -10,000 -2% $0.000000 480,000 25 Nov 2025 Class A Common Stock 10,000 $3.61 Direct F1
transaction NUVB Stock Option (Right to Buy) Options Exercise $0 -10,000 -2.1% $0.000000 470,000 26 Nov 2025 Class A Common Stock 10,000 $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.